AVEO Oncology
AVEO
$15.00
Share price
0.00%
Change (1 day)
170.76%
Change (1 year)
Categories
AVEO Oncology (AVEO) - Total debt
Total debt on the balance sheet as of September 2022 : $38.68 M
According to AVEO Oncology 's latest financial reports the company's total debt is $38.68 M. A company’s total debt is the sum of all current and non-current debts.
AVEO Oncology - Total debt on balance sheet (from 2008 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2021-12-31 | $37.97 M | 162.29% |
| 2020-12-31 | $14.47 M | -8.18% |
| 2019-12-31 | $15.76 M | -17.16% |
| 2018-12-31 | $19.03 M | 3.01% |
| 2017-12-31 | $18.47 M | 31.95% |
| 2016-12-31 | $14 M | 47.85% |
| 2015-12-31 | $9.47 M | -54.14% |
| 2014-12-31 | $20.65 M | 7.53% |
| 2013-12-31 | $19.2 M | -26.24% |
| 2012-12-31 | $26.03 M | 7.72% |
| 2011-12-31 | $24.17 M | 3.28% |
| 2010-12-31 | $23.4 M | 18.52% |
| 2009-12-31 | $19.74 M | -6.22% |
| 2008-12-31 | $21.05 M | 39.64% |
| 2007-12-31 | $15.07 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $25.22 B | 65,115.36% | 🇺🇸 USA |
 Amgen AMGN | $64.61 B | 166,944.98% | 🇺🇸 USA |
 Biogen BIIB | $7.33 B | 18,871.56% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | $2.70 B | 6,887.85% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $41.46 B | 107,097.52% | 🇺🇸 USA |
 Merrimack Pharmaceuticals MACK | $16.59 M | -57.09% | 🇺🇸 USA |